200 related articles for article (PubMed ID: 16344723)
21. Genotype-phenotype associations for common CYP3A4 and CYP3A5 variants in the basal and induced metabolism of midazolam in European- and African-American men and women.
Floyd MD; Gervasini G; Masica AL; Mayo G; George AL; Bhat K; Kim RB; Wilkinson GR
Pharmacogenetics; 2003 Oct; 13(10):595-606. PubMed ID: 14515058
[TBL] [Abstract][Full Text] [Related]
22. Ethnic differences between Japanese and Caucasians in the expression levels of mRNAs for CYP3A4, CYP3A5 and CYP3A7: lack of co-regulation of the expression of CYP3A in Japanese livers.
Yamaori S; Yamazaki H; Iwano S; Kiyotani K; Matsumura K; Saito T; Parkinson A; Nakagawa K; Kamataki T
Xenobiotica; 2005 Jan; 35(1):69-83. PubMed ID: 15788369
[TBL] [Abstract][Full Text] [Related]
23. Limited contribution of CYP3A5 to the hepatic 6beta-hydroxylation of testosterone.
Kamdem LK; Meineke I; Koch I; Zanger UM; Brockmöller J; Wojnowski L
Naunyn Schmiedebergs Arch Pharmacol; 2004 Jul; 370(1):71-7. PubMed ID: 15232676
[TBL] [Abstract][Full Text] [Related]
24. CYP3A4 and CYP3A5 genotypes, haplotypes, and risk of prostate cancer.
Plummer SJ; Conti DV; Paris PL; Curran AP; Casey G; Witte JS
Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):928-32. PubMed ID: 14504207
[TBL] [Abstract][Full Text] [Related]
25. Sex-dependent genetic markers of CYP3A4 expression and activity in human liver microsomes.
Schirmer M; Rosenberger A; Klein K; Kulle B; Toliat MR; Nürnberg P; Zanger UM; Wojnowski L
Pharmacogenomics; 2007 May; 8(5):443-53. PubMed ID: 17465708
[TBL] [Abstract][Full Text] [Related]
26. Analysis of CYP3A4 genetic polymorphisms in Han Chinese.
Zhou Q; Yu X; Shu C; Cai Y; Gong W; Wang X; Wang DM; Hu S
J Hum Genet; 2011 Jun; 56(6):415-22. PubMed ID: 21412247
[TBL] [Abstract][Full Text] [Related]
27. CYP3A4 and MDR1 alleles in a Portuguese population.
Cavaco I; Gil JP; Gil-Berglund E; Ribeiro V
Clin Chem Lab Med; 2003 Oct; 41(10):1345-50. PubMed ID: 14580164
[TBL] [Abstract][Full Text] [Related]
28. CYP3A5 genotype has significant effect on quinine 3-hydroxylation in Tanzanians, who have lower total CYP3A activity than a Swedish population.
Mirghani RA; Sayi J; Aklillu E; Allqvist A; Jande M; Wennerholm A; Eriksen J; Herben VM; Jones BC; Gustafsson LL; Bertilsson L
Pharmacogenet Genomics; 2006 Sep; 16(9):637-45. PubMed ID: 16906018
[TBL] [Abstract][Full Text] [Related]
29. MDR1 genotype is associated with hepatic cytochrome P450 3A4 basal and induction phenotype.
Lamba J; Strom S; Venkataramanan R; Thummel KE; Lin YS; Liu W; Cheng C; Lamba V; Watkins PB; Schuetz E
Clin Pharmacol Ther; 2006 Apr; 79(4):325-38. PubMed ID: 16580901
[TBL] [Abstract][Full Text] [Related]
30. Worldwide distribution of the MYH9 kidney disease susceptibility alleles and haplotypes: evidence of historical selection in Africa.
Oleksyk TK; Nelson GW; An P; Kopp JB; Winkler CA
PLoS One; 2010 Jul; 5(7):e11474. PubMed ID: 20634883
[TBL] [Abstract][Full Text] [Related]
31. Novel mutations of CYP3A4 in Chinese.
Hsieh KP; Lin YY; Cheng CL; Lai ML; Lin MS; Siest JP; Huang JD
Drug Metab Dispos; 2001 Mar; 29(3):268-73. PubMed ID: 11181494
[TBL] [Abstract][Full Text] [Related]
32. Extensive linkage disequilibrium, a common 16.7-kilobase deletion, and evidence of balancing selection in the human protocadherin alpha cluster.
Noonan JP; Li J; Nguyen L; Caoile C; Dickson M; Grimwood J; Schmutz J; Feldman MW; Myers RM
Am J Hum Genet; 2003 Mar; 72(3):621-35. PubMed ID: 12577201
[TBL] [Abstract][Full Text] [Related]
33. PXR pharmacogenetics: association of haplotypes with hepatic CYP3A4 and ABCB1 messenger RNA expression and doxorubicin clearance in Asian breast cancer patients.
Sandanaraj E; Lal S; Selvarajan V; Ooi LL; Wong ZW; Wong NS; Ang PC; Lee EJ; Chowbay B
Clin Cancer Res; 2008 Nov; 14(21):7116-26. PubMed ID: 18981011
[TBL] [Abstract][Full Text] [Related]
34. A comparative study of CYP3A4 polymorphisms in Mexican Amerindian and Mestizo populations.
Reyes-Hernández OD; Lares-Asseff I; Sosa-Macias M; Vega L; Albores A; Elizondo G
Pharmacology; 2008; 81(2):97-103. PubMed ID: 17952011
[TBL] [Abstract][Full Text] [Related]
35. Comparative analysis of CYP3A expression in human liver suggests only a minor role for CYP3A5 in drug metabolism.
Westlind-Johnsson A; Malmebo S; Johansson A; Otter C; Andersson TB; Johansson I; Edwards RJ; Boobis AR; Ingelman-Sundberg M
Drug Metab Dispos; 2003 Jun; 31(6):755-61. PubMed ID: 12756208
[TBL] [Abstract][Full Text] [Related]
36. CYP3A4-V and prostate cancer in African Americans: causal or confounding association because of population stratification?
Kittles RA; Chen W; Panguluri RK; Ahaghotu C; Jackson A; Adebamowo CA; Griffin R; Williams T; Ukoli F; Adams-Campbell L; Kwagyan J; Isaacs W; Freeman V; Dunston GM
Hum Genet; 2002 Jun; 110(6):553-60. PubMed ID: 12107441
[TBL] [Abstract][Full Text] [Related]
37. Natural protein variants of pregnane X receptor with altered transactivation activity toward CYP3A4.
Hustert E; Zibat A; Presecan-Siedel E; Eiselt R; Mueller R; Fuss C; Brehm I; Brinkmann U; Eichelbaum M; Wojnowski L; Burk O
Drug Metab Dispos; 2001 Nov; 29(11):1454-9. PubMed ID: 11602521
[TBL] [Abstract][Full Text] [Related]
38. Association between a CYP3A4 genetic variant and clinical presentation in African-American prostate cancer patients.
Paris PL; Kupelian PA; Hall JM; Williams TL; Levin H; Klein EA; Casey G; Witte JS
Cancer Epidemiol Biomarkers Prev; 1999 Oct; 8(10):901-5. PubMed ID: 10548319
[TBL] [Abstract][Full Text] [Related]
39. CYP3A5 3, CYP3A4 1B and MDR1 C3435T genotype distributions in Ecuadorians.
Sinués B; Vicente J; Fanlo A; Mayayo-Sinués E; González-Andrade F; Sánchez-Q D; Martínez-Jarreta B
Dis Markers; 2008; 24(6):325-31. PubMed ID: 18688081
[TBL] [Abstract][Full Text] [Related]
40. Identification and phenotype characterization of two CYP3A haplotypes causing different enzymatic capacity in fetal livers.
Rodríguez-Antona C; Jande M; Rane A; Ingelman-Sundberg M
Clin Pharmacol Ther; 2005 Apr; 77(4):259-70. PubMed ID: 15903124
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
